IMATINIB RESISTANCE MUTATION ANALYSIS; IRMA

  • Test Usage:
    Imatinib is a Tyrosine kinase inhibitor (TKI) capable of inducing durable hematologic and cytologic remissions in patients with Chronic Myeloid Leukemia (CML). Unfortunately a significant subset of patients develop functional resistance to TKI. Recognition of this resistance is important in CML as the effect of some mutations can be overcome by Imatinib dosage.
  • Report Availability:
    Sample by Mon 11 am; Report Sat
  • Sample Report:
2 Diagnostic Centers found for IMATINIB RESISTANCE MUTATION ANALYSIS; IRMA in Rajkot
  • B/4,Pushkandham,University Road,Rajkot, Guajrat-360005


    9409018786

    Collection Center
  • Matrukrupa 1, Shakti Colony, Behind A.G. Office, Kishan Para Chowk, Rajkot, Gujarat-360001


    7878408665

    latiadiagnostics@gtmail.comq

    Collection Center